DTDorottya Tarján

Dorottya Tarján

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dorottya Tarján has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Adriana Gherbon

    Department VII Internal Medicine ‐ Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology “Victor Babes” University of Medicine and Pharmacy Timisoara Romania

    1 shared publication
  • Ahmed Bouzid

    Department of General Surgery, Habib Bourguiba Hospital, University of Sfax , Sfax , Tunisia

    1 shared publication
  • Ahmed Saidani

    Department of General Surgery Mahmoud Matri Hospital Ariana Tunisia

    1 shared publication
  • Ahmed Tlili

    Department of General Surgery University Hospital of Gabes, Faculty of Medicine of Sfax Sfax Tunisia

    1 shared publication
  • Alexander N. Zolotov

    Central Research Laboratory, Department of Pathophysiology Omsk State Medical University Omsk Russia

    1 shared publication
  • Alexandra Mikó

    Institute for Translational Medicine Medical School University of Pécs Pécs Hungary

    1 shared publication

Latest Publications

  • Open Access

    Safety and Effectiveness of Cholecystectomy and Endoscopic Retrograde Cholangiopancreatography in Biliary Pancreatitis During Pregnancy: BORN Study

    by Dorottya Tarján, Eszter Ágnes Szalai, Bálint Erőss, Péter Jenő Hegyi, Vasile Liviu Drug, Serge Chooklin, Michael Hirth, Gabriel Sandblom, Vanessa Sandblom, Åsa Edergren, et al.

    Background: Biliary acute pancreatitis (AP) during pregnancy is a challenging situation, and current guidelines for AP, pregnancy care, and surgery do not specifically address its management. This study investigated the safety and effectiveness of cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP) during pregnancy in AP. Methods: This international retrospective multicenter cohort study encompassed questions related to demographic information, clinical presentation, management strategies, timing of cholecystectomy, approaches to the procedure, complications, and outcomes. Continuous variables were summarized as medians with interquartile ranges, and categorical variables as frequencies and percentages. Group comparisons used Welch's t ‐test, Pearson's chi‐squared, or Fisher's exact tests. Results: A total of 101 cases from 14 countries and 19 centers were enrolled. Cholecystectomy after mild AP during pregnancy had a lower rate of readmission due to recurrent AP or other gallstone‐related complications compared with those who did not undergo surgery after a mild AP during pregnancy (0% vs. 24%; n = 0/17 vs. n = 12/49, p = 0.027). Cholecystectomy performed during pregnancy was associated with a low surgical complication rate, identical to that seen in postpartum procedures (12% vs. 10%; n = 2/17 vs. n = 3/30; p > 0.999). Preterm birth occurred in 7.1% ( n = 1/14) of patients with cholecystectomy versus 11% ( n = 5/45) without. Fetal loss after surgery occurred only in the first trimester ( n = 3/17 vs. n = 1/49). No difference was seen in readmission (5%, n = 1/21 vs. 27%, n = 4/15; p = 0.138), fetal loss (5%, n = 1/21 vs. 27%, n = 4/15; p = 0.138) and preterm birth (6%, n = 1/17 vs. 8%, n = 1/12; p > 0.999) between the surgical and ERCP groups. The fetal loss (9.1%, n = 2/22 vs. 5.4%, n = 4/74; p = 0.618) and preterm birth rates (5.9%, n = 1/17 vs. 12%, n = 8/65; p = 0.677) did not significantly differ between patients with and without ERCP during pregnancy. Conclusion: Cholecystectomy is effective and safe in pregnant patients during the second or third trimester in cases of mild biliary pancreatitis. ERCP is safe in any trimester.